Peer reviewed medical research program
Ended Awarded Last action
- Contract number
- HT942525F0036
- Awardee
-
Leidos, Inc. UEI QLNMVC12KWY3 Part of Leidos Holdings, Inc.
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $462,270
Award facts
- Opportunity
-
- Meeting, Programmatic, and Administrative Support Services Pre-Solicitation · W81XWH22R0025 · Posted Aug 16, 2021
- Contract value 100% obligated
- $462,270.38 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Reston, VA 20190, USA
- Legislative mandates
-
- Walsh-Healey Public Contracts Act FAR subpart 22.6
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $323,401 | |
| Supplemental Agreement for work within scope | -$672,585 | |
| Original award | $811,454 |
About this award
Leidos, Inc., through its Leidos Services Operating Segment (doing business as SAIC), was awarded a delivery order valued at $462,270.38 by the Defense Health Agency for a Peer Reviewed Medical Research Program. The contract, which commenced on March 19, 2025, with an ultimate completion date of March 18, 2026, operates under a cost-plus-fixed-fee pricing structure with no set-aside designation, indicating competitive award to the established large contractor. Performance will be conducted in Herndon, Virginia. This delivery order falls under Leidos' broader portfolio of medical research support services, which historically encompasses research initiatives addressing conditions such as traumatic brain injury, cancer, and rare diseases across multiple federal health and defense agencies.
The Defense Health Agency, which oversees the military health system and conducts medical research in support of service member readiness and health, utilizes peer-reviewed research programs to advance medical knowledge applicable to military and veteran populations. Leidos' extensive experience supporting such initiatives through its Services Operating Segment positions the company to deliver the technical and administrative capabilities required under this contract. The company's track record includes significant research support work with agencies including the National Cancer Institute and National Institute of Allergy and Infectious Diseases, demonstrating established expertise in managing complex medical research programs and supporting federally funded research initiatives.
Quick answers
Who was awarded contract HT942525F0036?
HT942525F0036 was awarded to Leidos, Inc. by Defense Health Agency (Department of Defense) on March 19, 2025.
How much is contract HT942525F0036 worth?
The government has obligated $462,270 on HT942525F0036.
Is contract HT942525F0036 an order under another contract?
Yes. HT942525F0036 is a delivery order under HT942523D0002, an indefinite delivery contract.
Was contract HT942525F0036 competed?
The extent of competition for HT942525F0036 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award